Develops diagnostic tests for infectious diseases.
Jun 2026Revenue $2.67B/yrExpenses $3.50B/yr
Fell below break-even Jan 2024Cash runway ≈ 7 months from Jun 2026
Figures by year
When will QuidelOrtho be profitable again?
Its expenses passed its revenue in Jan 2024. In the 12 months to Jun 2026, revenue was $2.67B and expenses $3.50B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $2.73B | $3.65B | −$919M |
| Dec 2024 | $2.78B | $4.74B | −$1.96B |
| Dec 2023 | $3.00B | $2.86B | $139M |
| Jan 2023 | $3.27B | $2.42B | $844M |
| Jan 2022 | $1.70B | $793M | $906M |
| Jan 2021 | $1.66B | $601M | $1.06B |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.